TAE Life Sciences
  • OUR COMPANY
    • ABOUT US
    • LEADERSHIP TEAM
    • BOARD OF DIRECTORS
    • ADVISORS
    • CAREERS
  • ABOUT BNCT
    • HISTORY
    • HOW IT WORKS
    • BENEFITS OF BNCT
  • OUR TECHNOLOGIES
    • ALPHABEAM NEUTRON SYSTEM
    • TARGETED BORON DRUGS
  • NEWS
    • NEWS
    • EVENTS
  • CONTACT US
  • NEW EBOOK
  • OUR COMPANY
    • ABOUT US
    • LEADERSHIP TEAM
    • BOARD OF DIRECTORS
    • ADVISORS
    • CAREERS
  • ABOUT BNCT
    • HISTORY
    • HOW IT WORKS
    • BENEFITS OF BNCT
  • OUR TECHNOLOGIES
    • ALPHABEAM NEUTRON SYSTEM
    • TARGETED BORON DRUGS
  • NEWS
    • NEWS
    • EVENTS
  • CONTACT US
  • NEW EBOOK

TLS-News5_sm

Home > TAE Life Sciences and CNAO (National Center of Oncological Hadrontherapy) Announce a Research and Clinical Collaboration for the Implementation of a New Facility with Boron Neutron Capture Therapy System in Italy > TLS-News5_sm
October 27, 2020

Previous StoryTAE Life Sciences and CNAO (National Center of Oncological Hadrontherapy) Announce a Research and Clinical Collaboration for the Implementation of a New Facility with Boron Neutron Capture Therapy System in Italy

Sign up for our latest news and information

* indicates required




TAE Life Sciences, 19631 Pauling, Foothill Ranch, CA 92610

* The TAE Life Sciences device and drugs are in development and not available for sale or commercial use

Copyright ©2020 TAE Life Sciences. All Rights Reserved.